Caricamento...
NK cells mediate clearance of CD8(+) T cell–resistant tumors in response to STING agonists
Several immunotherapy approaches that mobilize CD8(+) T cell responses stimulate tumor rejection, and some, such as checkpoint blockade, have been approved for several cancer indications and show impressive increases in patient survival. However, tumors may evade CD8(+) T cell recognition via loss o...
Salvato in:
| Pubblicato in: | Sci Immunol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228660/ https://ncbi.nlm.nih.gov/pubmed/32198222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.aaz2738 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|